He is vice-chairman of the HOVON Myeloma Working Group and coordinates HOVON and EMN clinical trials. Professor Sonneveld helped to found the European Myeloma Network and has been chairman since. Within EMN, he coordinates a cooperative network for independent clinical trials in Europe. EMN currently runs international trials and registration trials for novel treatments.
He has been Board member and President (2017-2019) of the European Hematology Association EHA, and chair of its Scientific Working Group Committee. He has chaired the Scientific Program Committee of the 19th EHA congress in Milan 2014 and of the EMN Myeloma meetings in 2018 and 2021.
He serves on the Scientific Advisory Boards of the IMF and MMRF and is a member of the International Myeloma Working Group. Dr Sonneveld has been a member of many Editorial Boards and has authored more than 500 peer reviewed scientific publications and several book chapters. He has received numerous grants for his research.
In 2015 he was awarded the international Robert Kyle Award in Multiple Myeloma. In 2019 he received the Hubertus Wald Award for Cancer Research from Germany and in 2022 he received the International Waldenström Lifetime Achievement Award, this award is given by the International Myeloma Society.